Role of Lymphatic Deficiency in the Pathogenesis and Progression of Inflammatory Bowel Disease to Colorectal Cancer in an Experimental Mouse Model

Author:

Daley Sarah K1,Witte Marlys H2,Washington Jalicia2,Bernas Michael3,Kiela Pawel4,Thorn Jennifer1,Tanoue Nathan2,Alexander J Steven5

Affiliation:

1. Department of Pathology, University of Arizona, Tucson, Arizona

2. Department of Surgery, University of Arizona, Tucson, Arizona

3. Texas Christian University and University of North Texas Health Science Center School of Medicine, Fort Worth, Texas

4. Department of Pediatrics, University of Arizona, Tucson, Arizona

5. Department of Molecular and Cellular Physiology, Louisiana Health Sciences Center-Shreveport, Louisiana

Abstract

Abstract Background Inflammatory bowel disease (IBD) is characterized by chronic inflammation, which can progress to colorectal cancer, with duration of disease being the most important risk factor. Although many factors are involved, the pathogenic link between inflammation and cancer and the role played by the lymphatic system have not been fully investigated. This project uses lymphatic-deficient mice (Angiopoietin-2 [Ang2] knockout) to examine the lymphatic system in the progression of IBD to colorectal cancer. Methods Angiopoietin-2 wild-type, heterozygote, and knockout mice received a single injection of the procarcinogen azoxymethane and had an IBD-promoting chemical irritant (dextran sodium sulfate) added to their drinking water over a 7-week period. We measured disease activity (weight loss, stool consistency, fecal occult blood) during the study and at sacrifice, collected blood for cytokine/biomarker (Ang2, interleukin [IL] 1-β, IL-6, tumor necrosis factor α [TNFα], and VEGF-C) enzyme-linked immunosorbent assay analysis, measured colon length, and assessed tumor burden. Results Ang2 knockout (KO) mice exhibited reduced (55%) survival vs wild-type (100%) and heterozygotes (91%; P < 0.01 and P < 0.0001, respectively). Most (>89%) mice developed tumors, and the incidence of colorectal cancer did not differ among the genotypes (P = 0.32). The tumor area was significantly increased in KO mice (P = 0.004). Of the biomarkers measured in the serum, Ang2 and TNF-α concentrations were significantly different among the genotypes (P = 3.35e-08 and P = 0.003 respectively). Disease activity was significantly increased in KO mice compared with wild-type and heterozygote mice (P = 0.033). Conclusions Lymphatic deficiency, defective lymphangiogenesis, and impaired lymphatic-generated inflammation did not protect against clinical IBD or progression to colorectal cancer in this experimental model.

Funder

NIH

DOD

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference20 articles.

1. The risk of colorectal cancer in ulcerative colitis: a meta-analysis;Eaden;Gut.,2001

2. Inflammatory bowel disease as a risk factor for colorectal cancer;Lukas;Dig Dis.,2010

3. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies;Triantafillidis;Anticancer Res.,2009

4. Epithelial stem cells, wound healing and cancer;Arwert;Nat Rev Cancer.,2012

5. Inflammation and cancer;Coussens;Nature.,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3